Turning Point Brands, the publicly traded company with a presence in multiple segments of the nicotine and tobacco marketplace, confirmed today that some of its Premarket Tobacco Applications (PMTAs) have received Marketing Denial Orders from the FDA.
Other major brands in the independent vaping industry have also received MDOs this week for flavored e-liquids, including AVAIL Vapor.
These are believed to be the first MDOs issued to major companies that submitted extensive product-specific scientific evidence in their PMTAs.
“The PMTA denied by this MDO included an in-depth toxicological review, a clinical study, and studies on patterns and likelihood of use,” Turning Point said in a statement.
Jim McDonald – Vaping360 – 2021-09-17.
Want More Investigative Content?
